This review critically examines the association between proton pump inhibitor (PPI) use and the development of chronic kidney disease (CKD). Drawing from observational studies and pharmacoepidemiologic data, it highlights potential mechanisms such as acute interstitial nephritis leading to CKD. The article emphasizes the need for cautious PPI prescribing, especially in
